Cross-sectional and prospective relationships of interleukin-6 and C-reactive protein with physical performance in elderly persons: MacArthur studies of successful aging.

BACKGROUND Chronic inflammation has been proposed as a biological mechanism underlying the decline in physical function that occurs with aging. The purpose of this investigation was to examine the cross-sectional and prospective relationships between markers of inflammation, interleukin-6 (IL-6) and C-reactive protein (CRP), with several measures of physical performance in older persons aged 70 to 79 years. METHODS Subjects were 880 high-functioning men and women participating in the MacArthur Study of Successful Aging (n = 1189), a subset of the Established Populations for Epidemiologic Studies of the Elderly (n = 4030). Plasma IL-6 and CRP levels were determined by enzyme-linked immunosorbent assay and log transformed to normalize the distributions. Physical function measures included handgrip strength, signature time, chair stands (time to complete five repetitions), and 6-m walk time. RESULTS Women had lower (p < .05) IL-6 levels than men, but there was no significant difference between blacks and whites. IL-6 and CRP levels were higher (p < .05) in current smokers than in nonsmokers and in those with a greater body mass index (BMI). Hours per year undertaking moderate and strenuous physical activity were also related to inflammatory markers with higher (p < .001) IL-6 and CRP levels in less active individuals. After adjusting for age, sex, race, BMI, smoking status, use of nonsteroidal anti-inflammatory drugs, and prevalence of morbidity, those in the top two quartiles for walking speed had lower (p = .012) IL-6 levels than those in the bottom quartile. In addition, there was a trend (p = .038) for lower CRP levels in those with higher walking speed. CRP levels were also lower (p = .04) in individuals in the top quartile for grip strength. No significant differences were noted for chair stands or signature time performance. Repeat performance measures obtained on 405 subjects (67% of those eligible at baseline) obtained 7 years later had declined significantly (grip strength, 18%; signature time, 21%; walking speed, 31%; p < .001), except for the chair rise; however, baseline IL-6 and CRP were not associated with a change in performance. However, those who died or who were unable to undergo testing had higher baseline IL-6 and CRP levels (p < .01) and slower walking speed (p < .05). CONCLUSIONS Although IL-6 has been shown to predict onset of disability in older persons and both IL-6 and CRP are associated with mortality risk, these markers of inflammation have only limited associations with physical performance, except for walking measures and grip strength at baseline, and do not predict change in performance 7 years later in a high-functioning subset of older adults.

[1]  M. Schuster,et al.  Geriatric cachexia: the role of cytokines. , 1999, The American journal of clinical nutrition.

[2]  B. Pedersen,et al.  Elderly humans show prolonged in vivo inflammatory activity during pneumococcal infections. , 1999, The Journal of infectious diseases.

[3]  L. Kuller Serum Levels of IL‐6 and Development of Disability in Older Persons , 1999, Journal of the American Geriatrics Society.

[4]  Luigi Ferrucci,et al.  Serum IL‐6 Level and the Development of Disability in Older Persons , 1999, Journal of the American Geriatrics Society.

[5]  G. Krishnaswamy,et al.  Long-term exercise and atherogenic activity of blood mononuclear cells in persons at risk of developing ischemic heart disease. , 1999, JAMA.

[6]  H. Cohen,et al.  Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. , 1999, The American journal of medicine.

[7]  I. Kushner,et al.  Acute-phase proteins and other systemic responses to inflammation. , 1999, The New England journal of medicine.

[8]  D. Papanicolaou,et al.  The Pathophysiologic Roles of Interleukin-6 in Human Disease , 1998, Annals of Internal Medicine.

[9]  W. Rutishauser,et al.  C-reactive protein as a marker for acute coronary syndromes. , 1997, European heart journal.

[10]  L. Kuller,et al.  Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[11]  H J Cohen,et al.  The association of plasma IL-6 levels with functional disability in community-dwelling elderly. , 1997, The journals of gerontology. Series A, Biological sciences and medical sciences.

[12]  L H Kuller,et al.  Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[13]  P. Ridker,et al.  Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. , 1997, The New England journal of medicine.

[14]  T. Spector,et al.  Low-level increases in serum C-reactive protein are present in early osteoarthritis of the knee and predict progressive disease. , 1997, Arthritis and rheumatism.

[15]  G. Ciliberto,et al.  Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I. A model for stunted growth in children with chronic inflammation. , 1997, The Journal of clinical investigation.

[16]  J. Venkatraman,et al.  Exercise, immunity and aging , 1997, Aging.

[17]  R. Tracy,et al.  Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications. , 1997, Clinical chemistry.

[18]  A. Goldberg,et al.  Mechanisms of muscle wasting. The role of the ubiquitin-proteasome pathway. , 1996, The New England journal of medicine.

[19]  M. Hüll Interleukin-6-Associated Inflammatory Processes in Alzheimer's Disease: New Therapeutic Options , 1996 .

[20]  P. Vokonas,et al.  Periodontal Disease and Cardiovascular Disease. , 1996, Journal of periodontology.

[21]  R. Badolato,et al.  Role of cytokines, acute-phase proteins, and chemokines in the progression of rheumatoid arthritis. , 1996, Seminars in arthritis and rheumatism.

[22]  M. Hüll,et al.  Interleukin-6-associated inflammatory processes in Alzheimer's disease: New therapeutic options , 1996, Neurobiology of Aging.

[23]  G. Ciliberto,et al.  Elevated levels of interleukin-6 in unstable angina. , 1996, Circulation.

[24]  Roberto Pacifici,et al.  Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[25]  N. Grunnet,et al.  Short‐term changes in the immune system of elite swimmers under competition conditions: Different immunomodulation induced by various types of sport , 1996, Scandinavian journal of medicine & science in sports.

[26]  Cannon Jg Cytokines in Aging and Muscle Homeostasis , 1995 .

[27]  J. Sipe Acute-phase proteins in osteoarthritis. , 1995, Seminars in arthritis and rheumatism.

[28]  H J Cohen,et al.  Variability of plasma IL-6 and crosslinked fibrin dimers over time in community dwelling elderly subjects. , 1994, American journal of clinical pathology.

[29]  J. Bauer,et al.  Interleukin-6 and selected plasma proteins in healthy persons of different ages , 1994, Neurobiology of Aging.

[30]  A. Rebuzzi,et al.  The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. , 1994, The New England journal of medicine.

[31]  B. Riggs,et al.  Circulating levels of cytokines that modulate bone resorption: Effects of age and menopause in women , 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[32]  J. Gauldie,et al.  The acute phase response. , 1994, Immunology today.

[33]  M. Albert,et al.  High, usual and impaired functioning in community-dwelling older men and women: findings from the MacArthur Foundation Research Network on Successful Aging. , 1993, Journal of clinical epidemiology.

[34]  M. Fiatarone,et al.  The etiology and reversibility of muscle dysfunction in the aged. , 1993, Journal of gerontology.

[35]  C. Caspersen,et al.  A survey for assessing physical activity among older adults. , 1993, Medicine and science in sports and exercise.

[36]  J. Tobin,et al.  The role of muscle loss in the age-related decline of grip strength: cross-sectional and longitudinal perspectives. , 1990, Journal of gerontology.

[37]  W. Hollmann,et al.  C-Reactive Protein Serum Concentrations in Well-Trained Athletes* , 1982, International journal of sports medicine.

[38]  R. Paffenbarger,et al.  Physical activity as an index of heart attack risk in college alumni. , 1978, American journal of epidemiology.

[39]  A S Leon,et al.  A questionnaire for the assessment of leisure time physical activities. , 1978, Journal of chronic diseases.

[40]  Rupert G. Miller Simultaneous Statistical Inference , 1967 .